Australia markets close in 5 hours 42 minutes

NLS Pharmaceutics AG (NLSPW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.0311+0.0048 (+18.25%)
At close: 04:00PM EDT
0.0300 -0.00 (-3.54%)
After hours: 07:23PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-12,172
-12,172
-16,496
-11,946
-2,861
-
Depreciation & amortisation
11.408
11.408
11.408
10.05
0
-
Stock-based compensation
164.906
164.906
22.73
0
0
-
Change in working capital
2,252
2,252
1,627
-3,167
2,040
-
Accounts payable
2,260
2,260
636.263
-2,269
1,497
-
Other working capital
-9,684
-9,684
-13,879
-14,976
-729.386
-
Other non-cash items
-
-
989.503
41.611
72.188
1,121
Net cash provided by operating activities
-9,684
-9,684
-13,879
-14,936
-729.386
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-39.56
-
-
Net cash used for investing activities
0
0
0
-39.56
0
-
Cash flows from financing activities
Debt repayment
0
0
-704.16
-2,213
0
-
Common stock issued
0
0
9,218
14,550
0
-
Other financing activities
-
-
-
-
-686.701
-260.211
Net cash used provided by (used for) financing activities
1,634
1,634
17,397
20,338
503.522
-
Net change in cash
-8,051
-8,051
3,517
5,337
-126.556
-
Cash at beginning of period
8,948
8,948
5,431
93.711
220.267
-
Cash at end of period
897.68
897.68
8,948
5,431
93.711
-
Free cash flow
Operating cash flow
-9,684
-9,684
-13,879
-14,936
-729.386
-
Capital expenditure
-
-
-
-39.56
-
-
Free cash flow
-9,684
-9,684
-13,879
-14,976
-729.386
-